Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Thursday, April 18, 2024

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

Ajeenkya D Y Patil Healthcare Awards an Approximate 100 Mn USD...

New Delhi, August 06, 2021: The domestic healthcare player - Ajeenkya D Y Patil Group in a step towards concreting their aspirations to be a...

Biotechnology

ESDS launches AA+ Covid 19 testing solution that indicates disease in less than 5...

Nashik,  May 20, 2020: One of India’s leading IT Solution company, ESDS Software Solution Pvt. Ltd. has come up with a rapid COVID-19 detection solution,...

IT & Software Support

Appointments

Awards

Convocation of ISF College of Pharmacy,

New Delhi, April 12, 2019: ISF College of Pharmacy, Moga Convocation-2019 was held on Tuesday, 19th March 2019 in the Campus. The Chief guest for...

Cankids NGO, organizes the 11th National Childhood Cancer Excellence Award Program for children with...

New Delhi, September 30, 2019: Cankids Kidscan – organized the 11th National Childhood Cancer Excellence Award Program for children with Cancer, who have either survived the...

Financial Results

Approvals

Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has granted marketing authorization for...

Clinical Trails

MBRKA Nominations Invited from Individuals and Organizations Working to Add Knowledge in Dealing with...

New Delhi, August 12, 2020: Sheikh Mohammed Bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai issued...

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Dr. Agarwals Eye Hospitals opens high-end eyecare facility in Chembur, its 10th in Mumbai

Mumbai, October 05, 2023:  Dr. Agarwals Eye Hospitals has opened a state-of-the-art eyecare hospital in Chembur, Mumbai, at Signature Business Park. The facility, spread...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Homeopathy Can Help Cancer Patients Live Longer, Says Doctor

BENGALURU, November 29,  2023 :  During the launch of Dr. Kalyan Banerjee's Clinic in Bengaluru, Dr. Kushal Banerjee, Senior Homeopath at the facility, shed...

Haslab Joins Hands with 3EA to Bring Homeopathy to the Forefront

Mumbai, April 04, 2019: The homeopathy sector is ready to witness a new benchmark. Haslab and 3EA have released a detailed study to address the massive challenges faced...

Women going to courts under 20 weeks gestation with MTP request, finds Pratigya Campaign...

~A legal analysis of Supreme Court and High Court Judgements in India to assess the judiciary’s role in access to safe abortion conducted by...

Dental Care

India’s leading dental chainoffers new year gift to crooked teeth patients – Clove InvisiBraces

Clove Dental has come up with special offers for its just launched invisible Aligners, a highly innovative alternative to existing metal braces  New Delhi, January...

Hospital Management

HCG Cancer Hospital completes Comprehensive Genomic Profi­ling (CGP) of 1000+ Cancer Patients

Bengaluru , August 22, 2023: Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer...

Drug Discovery & Development

Eisai Center for Genetics Guided Dementia Discovery Commences Full-Scale Operation Toward Innovative Dementia Treatments...

A Focused Drug Discovery Approach That Integrates Human Genetics/ Data Science/ Precision Chemistry Tokyo, July 10, 2019: Eisai Co., Ltd. has announced that the Eisai...

Suppliers

Technology

Thyrocare designs Mobile Collection Facility and shares them to reduce the...

Thyrocare, lab based in Mumbai, designs a low cost model to convert every ambulance into Mobile collection facility (MCF) to enable labs to reach...

Companies

Stakeholders convene in New Delhi to commit to accelerating cervical cancer...

New Delhi, December 13,  2023 : A policy consultation on cervical cancer screening and treatment held on 8 December in New Delhi demonstrated the...

Marketing

Our Partners

Machinery & Equipments